More about

Type 2 Diabetes

News
August 15, 2022
2 min read
Save

Patients with CKD, type 2 diabetes likely to progress to high risk within 5 years

Patients with CKD, type 2 diabetes likely to progress to high risk within 5 years

In a 5-year period, 18.9% of patients with chronic kidney disease and type 2 diabetes progressed from moderate or high baseline risk to very high risk.

News
August 10, 2022
1 min read
Save

FDA: Possibly contaminated sitagliptin may be distributed to avoid shortage

FDA: Possibly contaminated sitagliptin may be distributed to avoid shortage

The FDA announced it has learned that some samples of sitagliptin, used to treat type 2 diabetes, may contain a “nitrosamine impurity,” Nitroso-STG-19 or NTTP, which may be a human carcinogen.

News
August 09, 2022
2 min read
Save

Insulin use, older age raise risk for clinically significant nocturnal hypoglycemia

Insulin use, older age raise risk for clinically significant nocturnal hypoglycemia

Insulin use, older age, lower fasting glucose and lower estimated glomerular filtration rate are associated with increased odds for clinically significant nocturnal hypoglycemia in older adults with type 2 diabetes, according to study data.

News
August 05, 2022
2 min read
Save

Intensive lifestyle changes associated with diabetes remission by 3 months

Intensive lifestyle changes associated with diabetes remission by 3 months

LOUISVILLE, Ky. — Adults with prediabetes or type 2 diabetes participating in a program with tailored diet and exercise programs had improved insulin sensitivity measures by 3 months, with some participants achieving diabetes remission.

News
August 03, 2022
1 min read
Save

Top in endocrinology: Time-restricted eating; vitamin D supplementation

Top in endocrinology: Time-restricted eating; vitamin D supplementation

A recent study showed that a time-restricted eating window of 10 hours vs. 14 hours decreased glucose and improved time in range among adults with type 2 diabetes.

News
August 01, 2022
1 min read
Save

Top news from ADA: Tirzepatide, cell therapy, glucokinase inhibition and more

Top news from ADA: Tirzepatide, cell therapy, glucokinase inhibition and more

The Healio and Endocrine Today editors have compiled the most read news from the American Diabetes Association Scientific Sessions in June.

News
July 26, 2022
3 min read
Save

Time-restricted eating decreases glucose, improves time in range in type 2 diabetes

Time-restricted eating decreases glucose, improves time in range in type 2 diabetes

Adults with type 2 diabetes had lower fasting glucose and increased time in range with a time-restricted eating window of 10 hours compared with an eating window of 14 hours or longer, according to study data.

News
July 19, 2022
2 min read
Save

Memory complaints linked to lower self-reported type 2 diabetes medication adherence

Memory complaints linked to lower self-reported type 2 diabetes medication adherence

Adults with type 2 diabetes and more memory complaints are more likely to underreport medication adherence compared with those with fewer memory complaints, according to study data.

News
July 18, 2022
2 min read
Save

Type 2 diabetes incidence '30 times greater' for children with NAFLD vs. high-risk groups

Type 2 diabetes incidence '30 times greater' for children with NAFLD vs. high-risk groups

Researchers reported an increased risk for type 2 diabetes in children with nonalcoholic fatty liver disease, highlighting the need for targeted prevention and screening, according to a study in Clinical Gastroenterology and Hepatology.

News
July 18, 2022
2 min read
Save

Provider contact, COVID-19 risk among concerns for adults with diabetes during pandemic

Provider contact, COVID-19 risk among concerns for adults with diabetes during pandemic

Adults with type 2 diabetes described difficulties with contacting health care providers and receiving information about links between diabetes and COVID-19 during the pandemic, according to findings from a qualitative study.

View more